UiPath, Inc. (NYSE:PATH) is one of the cheap AI stocks to buy in 2026. On February 23, 2026, UiPath announced a suite of ...

UiPath (NYSE:PATH) has launched agentic AI automation tools tailored for healthcare providers and payers. The company is ...

Robotic process automation (RPA) tools are paving the way for greater productivity, more precision, and accelerated digital transformation for businesses across all industries. There are many tools on ...

​UiPath, Inc. (NYSE:PATH) is one of the Best All-Time Low Stocks to Invest In Now. On February 23, UiPath, Inc. (NYSE:PATH), ...

Robotic process automation (RPA) is a technology that allows enterprises to automate some or all of their business processes. You can think of it as digital workers, which mimic manual tasks, so they ...

UiPath’s blended fair value estimate has been trimmed from US$16.19 to US$15.93, a move that sits alongside bullish analyst price targets up to US$18 and recent target cuts from more cautious voices.

UiPath Inc. today announced a preview of its upcoming Agent Builder tool as it outlined its vision to combine its expertise in robotic process automation with generative artificial intelligence models ...

NEW YORK & LAS VEGAS - UiPath (NYSE: PATH), a prominent enterprise automation software firm, revealed the introduction of its new AI-based medical record summarization tool at Google Cloud Next 2025.

Join our daily and weekly newsletters for the latest updates and exclusive content on industry-leading AI coverage. Learn More “In three to five years, RPA and AI will become a commodity productivity ...